Gilead Sciences (GILD) Non-Current Deffered Revenue (2009 - 2013)

Gilead Sciences (GILD) has 5 years of Non-Current Deffered Revenue data on file, last reported at $22.0 million in Q4 2013.

• Quarterly Non-Current Deffered Revenue rose 7.05% year-over-year to $22.0 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $22.0 million (up 7.05% YoY) and the FY2013 annual result came in at $22.0 million, up 7.05% from the prior year.
• Non-Current Deffered Revenue eased to $22.0 million in Q4 2013, from $25.4 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $53.4 million in Q2 2009 to a low of $20.5 million in Q4 2012.
• A 5-year average of $32.2 million and a median of $31.1 million in 2011 frame the typical range for Non-Current Deffered Revenue.
• Annual changes were most pronounced in 2012 — Non-Current Deffered Revenue sank 39.96% — and 2013, when it grew 21.89%.
• Tracing GILD's Non-Current Deffered Revenue over 5 years: stood at $43.0 million in 2009, then retreated by 23.66% to $32.8 million in 2010, then retreated by 2.97% to $31.9 million in 2011, then slumped by 35.58% to $20.5 million in 2012, then gained by 7.05% to $22.0 million in 2013.
• The last three Non-Current Deffered Revenue figures came in at $22.0 million (Q4 2013), $25.4 million (Q3 2013), and $28.8 million (Q2 2013), per Business Quant data.